Register or Login
Catalog #
  • All
  • Uniprot Id
  • Catalog #
>   home   >   Products   >   Antibodies   >   ELAVL1 antibody (Ascites)   

ELAVL1 antibody (Ascites)

Mouse Monoclonal Antibody (Mab)

United States
AlbaniaAustraliaAustriaBelgiumBosnia & HerzegovinaBrazilBulgariaCanadaChinaCroatiaCyprusCzech RepublicDenmarkEstoniaFinlandFranceGermanyGreeceHong KongHungaryIcelandIndiaIndonesiaIrelandIsraelItalyJapanKoreaLatviaLithuaniaLuxembourgMacedoniaMalaysiaMaltaNetherlandsNew ZealandNorwayPakistanPolandPortugalRomaniaSerbiaSingaporeSlovakiaSloveniaSouth AfricaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUnited StatesVietnamOthers
Ordering Information
Catalog # SizeAvailability Price  
AM1899a 0.1 ml In Stock $ 265.00 Add to cart
  • Specification
  • Citations : 0
  • Reviews
  • Protocols
  • Background

ELAVL1 antibody (Ascites) - Product Information

  • Applications Legend:
  • WB=Western Blot
  • IHC=Immunohistochemistry
  • IF=Immunofluorescence
  • FC=Flow Cytopmetry
  • IP=Immunoprecipitation
  • DB=Dot Blot
  • ICC=Immunocytochemistry
  • CHIP=Chromatin Immunoprecipitation
  • IHCF=Immunohistochemistry (Frozen Sections)
  • FA=Fluorescence Assay
  • IHCP=Immunohistochemistry (Paraffin-embedded Sections)
  • IC=Immunochemistry
  • IEM=Immunoelectronmicroscopy
  • EIA=Enzyme Immunoassay
Primary AccessionQ15717
Other AccessionNP_001410.2
Isotype IgG1,K
Clone Names224CT6.5.3
Calculated MW 36092 Da

ELAVL1 antibody (Ascites) - Additional Information

Gene ID 1994
Other Names
ELAV-like protein 1, Hu-antigen R, HuR, ELAVL1, HUR
This ELAVL1 monoclonal antibody is generated from mouse immunized with ELAVL1 recombinant protein.
Mouse monoclonal antibody supplied in crude ascites with 0.09% (W/V) sodium azide.
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
ELAVL1 antibody (Ascites) is for research use only and not for use in diagnostic or therapeutic procedures.

ELAVL1 antibody (Ascites) - Protein Information

Synonyms HUR
RNA-binding protein that binds to the 3'-UTR region of mRNAs and increases their stability. Involved in embryonic stem cells (ESCs) differentiation: preferentially binds mRNAs that are not methylated by N6-methyladenosine (m6A), stabilizing them, promoting ESCs differentiation. Binds to poly-U elements and AU- rich elements (AREs) in the 3'-UTR of target mRNAs. Binds avidly to the AU-rich element in FOS and IL3/interleukin-3 mRNAs. In the case of the FOS AU-rich element, binds to a core element of 27 nucleotides that contain AUUUA, AUUUUA, and AUUUUUA motifs. Binds preferentially to the 5'-UUUU[AG]UUU-3' motif in vitro. With ZNF385A, binds the 3'-UTR of p53/TP53 mRNA to control their nuclear export induced by CDKN2A. Hence, may regulate p53/TP53 expression and mediate in part the CDKN2A anti-proliferative activity. May also bind with ZNF385A the CCNB1 mRNA.
Cellular Location
Cytoplasm. Nucleus. Note=Translocates into the cytoplasm following phosphorylation by MAPKAPK2
Tissue Location

ELAVL1 antibody (Ascites) - Related Products

AM1899B: ELAVL1 Antibody

AP8963a: ELAVL1 Antibody

AT1891a: ELAVL1 Antibody (monoclonal) (M02)

AP50916: ELAVL1 Antibody

AP52000: HUR Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at

Thank you for your support.


Provided below are standard protocols that you may find useful for product applications.


The protein encoded by this gene is a member of the ELAVL protein family. This encoded protein contains 3 RNA-binding domains and binds cis-acting AU-rich elements. It destabilizes mRNAs and thereby regulates gene expression.


Tholanikunnel, B.G., et al. J. Biol. Chem. 285(44):33816-33825(2010)
Drury, G.L., et al. J. Biol. Chem. 285(41):31130-31138(2010)
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)
Raspaglio, G., et al. Cancer Res. 70(14):5891-5900(2010)
Ahn, J., et al. Retrovirology 7, 40 (2010) :